Kadowaki_2017_Expert.Opin.Pharmacother_18_1291

Reference

Title : Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period - Kadowaki_2017_Expert.Opin.Pharmacother_18_1291
Author(s) : Kadowaki T , Kondo K , Sasaki N , Miyayama K , Yokota S , Terata R , Gouda M
Ref : Expert Opin Pharmacother , 18 :1291 , 2017
Abstract : Kadowaki_2017_Expert.Opin.Pharmacother_18_1291
ESTHER : Kadowaki_2017_Expert.Opin.Pharmacother_18_1291
PubMedSearch : Kadowaki_2017_Expert.Opin.Pharmacother_18_1291
PubMedID: 28741385

Related information

Citations formats

Kadowaki T, Kondo K, Sasaki N, Miyayama K, Yokota S, Terata R, Gouda M (2017)
Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period
Expert Opin Pharmacother 18 :1291

Kadowaki T, Kondo K, Sasaki N, Miyayama K, Yokota S, Terata R, Gouda M (2017)
Expert Opin Pharmacother 18 :1291